Parametric Release in Ethylene Oxide Sterilization: A New Era for Efficiency and Compliance

For decades, long aeration times and extended biological indicator (BI) incubation periods have challenged medical device manufacturers relying on ethylene oxide (EtO) sterilization. This situation often resulted in delayed product availability, longer supply chain cycles, and increased costs. However, the emergence of parametric release is changing this picture. With support from industry experts and updated international standards, parametric release is increasingly recognized as a feasible and safe practice, offering manufacturers the opportunity to achieve faster turnaround while maintaining sterility assurance.

 

What Is Parametric Release in EtO Sterilization?

Parametric release refers to the approval of sterilized products based on documented evidence that all critical process parameters were achieved and controlled, rather than relying on BI test results after incubation. For radiation sterilization (gamma and electron beam) and steam sterilization, this has long been the standard practice. Parameters such as dose, time, and temperature are verified against validated ranges, and once compliance is confirmed, products are released.

EtO sterilization, however, is more complex. Because EtO relies on the interaction of multiple variables-gas concentration, humidity, temperature, exposure time, pressure cycles, and aeration-it has traditionally depended on BI testing for final release. This approach, while conservative, leads to cycle times as long as 7–11 days, especially when BI processing is delayed by weekends or holidays.

Parametric release for EtO, therefore, represents a major step forward. By ensuring validated control of all critical variables and continuous monitoring during routine cycles, manufacturers can bypass BI-based delays, releasing products much sooner-sometimes within 40–48 hours.

 

Historical and Regulatory Context

Efforts to formalize parametric release for EtO are not new. The ANSI/AAMI ST27 standard (1988) briefly acknowledged process control release but lacked detail, limiting its adoption. In 1994, the introduction of ANSI/AAMI/ISO 11135 marked significant progress, providing a comprehensive framework for validation, control, and routine parametric release. Annex D of ISO 11135 offered further guidance, covering expertise requirements, load temperature distribution, recirculation monitoring, and performance qualification.

The ongoing work by the Association for the Advancement of Medical Instrumentation (AAMI), including technical information reports (TIRs), continues to refine expectations around equipment design, validation methodology, and monitoring requirements. These efforts collectively strengthen industry confidence that parametric release can meet the highest sterility assurance levels (SAL 10⁻⁶) while remaining compliant with regulators such as the FDA and EU authorities.

 

Benefits and Challenges of Parametric Release

Benefits:

Shortened Turnaround: Products can be released in 2–3 days instead of waiting 7–11 days.

Supply Chain Flexibility: Enables manufacturers to adopt just-in-time (JIT) inventory models, reducing storage and capital costs.

Reduced Handling Risks: Eliminates the need to open cartons to insert or retrieve BIs, minimizing potential product damage.

Lower Operational Costs: Decreases BI-related expenses, including purchasing, placement, retrieval, and laboratory testing.

Improved Market Responsiveness: Enhances ability to react quickly to demand surges or urgent healthcare needs.

Challenges:

High Initial Investment: Requires advanced sterilizers with precise sensors, data logging, and gas analysis systems.

Validation Complexity: Manufacturers must complete rigorous installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) under worst-case load conditions.

Temperature and Humidity Control: Large industrial chambers must demonstrate consistent distribution to avoid "cold spots."

Training and Communication: Teams must be trained in interpreting process data, and effective communication with contract sterilizers and customers is essential.

 

Impact on EO Sterilizer Design

To support parametric release, sterilizers must evolve beyond traditional designs. Key features include:

Advanced Control Systems: Real-time monitoring of temperature, humidity, EO concentration, and pressure, with automated data acquisition.

Data Integrity: Compliance with 21 CFR Part 11 and international electronic records standards for audit readiness.

Enhanced Aeration: Effective degassing systems ensuring EO residues meet ISO 10993-7 requirements.

Flexible Load Management: Ability to validate and monitor complex load configurations, including identification of cold spots.

Modern EO sterilizers are no longer just chambers for gas exposure-they are integrated systems combining engineering precision, data science, and compliance management.

 

The Role of Hangzhou Riches Engineering Co., LTD.

As a leading innovator in sterilization technology, Hangzhou Riches Engineering Co., LTD. is well-positioned to help the industry transition toward parametric release.

Expert Team: With years of deep involvement in the pharmaceutical and sterilization industries, Riches' engineers bring unmatched expertise in EtO sterilization processes.

Turnkey Solutions: From design and validation to installation, training, and after-sales service, Riches provides one-stop solutions tailored to customer needs.

Cutting-Edge Sterilizers: Riches EO Sterilizers are designed with advanced process control, precision monitoring, and compliance-ready data management, making them ideal for parametric release applications.

Global Experience: With proven project management across international markets, Riches supports both in-house sterilization facilities and contract sterilization providers.

Innovation-Driven: Committed to helping customers improve efficiency, reduce costs, and achieve regulatory compliance, Riches stands at the forefront of EtO sterilization evolution.

 

Conclusion

Parametric release in EtO sterilization is more than just a technical adjustment-it represents a paradigm shift in how medical devices are sterilized, validated, and delivered to market. By reducing cycle times, improving process reliability, and aligning with global efficiency trends, it offers manufacturers a competitive advantage while maintaining patient safety.

For companies seeking to adopt this approach, partnering with experienced suppliers is essential. With its strong engineering expertise, turnkey capabilities, and advanced EO sterilizer technology, Hangzhou Riches Engineering Co., LTD. provides the tools and support needed to embrace parametric release and lead in the next generation of sterilization practices.